• BS, Philadelphia College of Pharmacy and Science
• PhD, The Johns Hopkins University School of Medicine
• Postdoctoral Fellow in Oncology, The Johns Hopkins School of Medicine
Johns Hopkins Center
Johns Hopkins scientists use pap test fluid to detect ovarian, endometrial cancers
Using cervical fluid obtained during routine Pap tests, scientists at the Johns Hopkins Kimmel Cancer Center have developed a test to detect ovarian and endometrial cancers. In a pilot study, the “PapGene” test, which relies on genomic sequencing of cancer-specific mutations, accurately detected all 24 (100 percent) endometrial cancers and nine of 22 (41 percent) ovarian cancers. Results of the experiments are published in the Jan. 9 issue of the journal Science Translational Medicine.
Our Center is focused on identifying the genetic alterations responsible for human tumorigenesis and exploiting this knowledge to manage patients with cancer.